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doi:10.1Objective: To identify the role of institution and surgeon factors, including case volume and experience, on sur-
vival of neonates with complex congenital heart disease.
Methods: A total of 2421 neonates from 4 groups—transposition of the great arteries (n ¼ 829), pulmonary atre-
sia with intact ventricular septum (n ¼ 408), Norwood (n ¼ 710), and interrupted aortic arch (n ¼ 474)—were
prospectively enrolled from Congenital Heart Surgeons Society institutions. Multivariable analysis of risk-ad-
justed survival was performed for each group, entering each institution or surgeon into the multivariable analysis
separately. Institutional performance was defined as [predicted survival – actual survival]. Neutralization of risk
factors within each institution was evaluated using complex interaction terms. Institution and surgeon experience,
defined by 5 domains (total case volume, total time each operation was performed, cases per year, rank-order of
cases, case velocity), were also investigated.
Results: Institutional performance varied among all groups. Improved outcomes in Norwood and pulmonary
atresia with intact ventricular septum were unrelated to any ‘‘experience’’ domains, whereas improved outcomes
in transposition of the great arteries were significantly related to increased experience in most domains. No insti-
tution enrolling in all 4 studies ranked number 1 in performance for all groups. Neutralization of low birth weight
as a risk factor contributed to decreased mortality after Norwood in one institution.
Conclusion: Survival of neonates with complex congenital heart disease is influenced more by patient and man-
agement factors than by institution or surgeon experience. Institutional excellence in managing some diagnostic
groups does not indicate similar performance for all diagnostic groups. Weighted risk-adjusted comparisons could
provide a mechanism to improve results in institutions with less than optimal outcomes. (J Thorac Cardiovasc Surg
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The Journal of Thoracic and CaThere is considerable interest in establishing criteria for com-
paring surgical outcomes for congenital heart disease (CHD)
among institutions and surgeons. Evidence from other surgi-
tion or surgeon ‘‘experience’’ may confer an outcome bene-
fit.1-10 However, the data are conflicting and often obtained
from statistical models that are risk stratified for groups of pa-
tients with similar characteristics rather than risk adjusted for
individual patients.11 Inadequate risk adjustment is partly
due to the source datasets from which statistical models are
constructed (ie, registry or administrative databases that by
definition are minimum datasets with variables identified
by consensus rather than comprehensive academic datasets
with data-derived risk factors12), and partly from a lack of
consensus regarding the end point for comparison.11,13-17
Inferences regarding the importance of institution and sur-
geon experience on patient outcomes are therefore hampered
by inadequate power, confounding influences of era and cu-
mulative experience, shifts in the composition of surgical
teams, differing case-mix among institutions, current lowrdiovascular Surgery c Volume 139, Number 3 569
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D57Abbreviations and Acronyms0CHD ¼ cThe Jongenital heart diseaseCHSS ¼ Congenital Heart Surgeons Society
IAA ¼ interrupted aortic arch
PAIVS ¼ pulmonary atresia with intact ventricular
septumTGA ¼ transposition of the great arteriesoperative risk, and the differential importance of patient and
technical factors among diagnostic groups.11,14,15,18-20
We sought to use comprehensive diagnosis-based data-
sets (with the exception of the Norwood) derived from Con-
genital Heart Surgeons Society (CHSS) multi-institutional
studies to overcome these problems and create risk-adjusted
models to determine the role of institutional and surgeon ex-
perience on outcomes for neonates with complex CHD.
MATERIALS AND METHODS
Patients and Institutions
A total of 2421 neonates from 4 groups (transposition of the great arteries
[TGA], Norwood, interrupted aortic arch [IAA], and pulmonary atresia with
intact ventricular septum [PAIVS]) were prospectively enrolled from 24 to
33 CHSS institutions. Outcomes for all of these neonates, including the spe-
cific patient and procedural characteristics, have been reported.15,21-24 Par-
ticipation in the study and submission of patient information was voluntary
and confidential. Parental consent was obtained consistent with individual
institutional policies. Ethics approval for the CHSS Data Center is obtained
annually from the Hospital for Sick Children in Toronto. Enrollment period,
institution, and surgeon characteristics for each group are shown in Table 1.
Data Analysis
Data are presented as frequency, median with range, or mean  standard
deviation as appropriate, with the number of missing values indicated. Percent-
ages, hazard functions, and competing risk estimates are presented with con-
fidence limits equivalent to 1 standard error (68%). All data analyses were
performed using SAS statistical software (version 9; SAS Institute Inc,
Cary, NC). Multiphase parametric modeling of the hazard function16,17 and
competing risks methodology22,25-29 were used to determine rates of transition
to mutually exclusive time-related events and identify incremental risk factors
associated with each transition rate as previously described.16,17,22,25-29 Trans-
formations to linearize variables and to optimize calibration to risk for contin-
uous predictors were considered in all multivariable analyses. Variable
selection was primarily by bootstrap bagging, with those variables having
greater than 50% reliability included in the final models.17,22
Statistical Models
Overall risk-adjusted parametric mortality models were constructed on the
basis of the total experience of all institutions, accounting for patient, demo-
graphic, and procedural factors that influence mortality for the entire diagnos-
tic group. The overall mortality models for each group were specified a priori,
meaning that we used the previously reported overall mortality model for
each diagnostic group15,21-24 (Table E1). However, the importance of risk
factors affecting overall outcomes may or may not apply equally to each in-
dividual institution. We addressed this problem using the following methods
to account for potential variation within each institution: (1) Each institution
was forced into the overall model for each diagnostic group (ie, to determine
whether that particular institution conferred an increased or decreased risk);ournal of Thoracic and Cardiovascular Surg(2) interaction terms were then created with each risk factor within the overall
model to determine whether improved or reduced institutional performance
could be explained by neutralization of known risk factors for the entire co-
hort; (3) institutional ‘‘experience’’ was then incorporated as an explanatory
variable to define whether these factors improved performance discrimina-
tion; and (4) actual institutional performance at an individual institution
was compared with the expected risk-adjusted mortality at that institution
on the basis of all identified risk factors. Institutional ‘‘experience’’ was eval-
uated using the following 5 separate domains:
(1) total case volume (the total number of patients enrolled at each institution during
the entire study enrollment period);
(2) total time period (years) in which each institution was performing a particular pro-
cedure (the difference in years between the date of the last procedure and the date
of the first procedure during the study enrollment period; for example, if institution
‘‘X’’ enrolled their first patient with an arterial switch operation in 1985 and en-
rolled their last patient with an arterial switch in 1989, this value would be 4 years);
(3) cases per year (the total number of patients enrolled by each institution divided by
the number of years in which that institution enrolled patients in each study);
(4) rank order of cases (the first case through the last case in consecutive order); and
(5) case velocity over time (the rank order of each case divided by the time interval
(number 2 above) in which a particular procedure was performed).
Surgeon ‘‘experience’’ was likewise evaluated using the same 5 domains
but was considered only in Norwood and TGA, the only 2 groups with avail-
able surgeon-level data. The effect of era was considered by incorporating
the date at which each institution or surgeon enrolled their first patient un-
dergoing a particular procedure as an explanatory variable.
RESULTS
Impact of Institutional Experience Factors on
Mortality
Impact of institution ‘‘experience’’ factors on risk-ad-
justed overall 5-year mortality after admission is shown in
Table 2. In complex procedures, such as the Norwood, there
was no apparent survival benefit conferred by increased in-
stitution ‘‘experience’’ in any of the 5 domains investigated
(Figure 1). Improved results in management of neonates
with PAIVS were also not significantly related to increased
institution experience (Table 2).
However, in TGA, improved 5-year survival is significantly
associated with increasing institutional experience in 4 of the 5
domains investigated (Table 2). Lower annual TGA case vol-
ume, with a threshold value of less than 50 cases per year, re-
sulted in significantly increased mortality (Figure 2, A). The
improvement in mortality, though, was due to improved out-
comes for the arterial switch (n¼ 516) rather than for the atrial
switch (n¼ 276), in which the risk did not change significantly
(Figure 2, B). For the arterial switch, increased case velocity
over time was associated with decreased mortality (parameter
estimate:0.06 0.13 per case; P<.001). Similarly, mortal-
ity was inversely related to increased total procedure time that
each institution had with the arterial switch (parameter esti-
mate:0.24 0.10 per year; P¼ .01). However, for the atrial
switch, there was no significant survival benefit conferred by
any of the experience domains considered.
Institutional Performance
There was considerable variation in institutional perfor-
mance among the different lesion sets (Figure 3, A–D). Noery c March 2010
TABLE 1. Institution and surgeon characteristics for each diagnostic
group
Variable Value
I. Norwood
Enrollment period 1994–2000
Total no. of patients 710
No. of institutions 29
Total cases (median and range) 6 (1–155)
Cases per year (median and range) 14 (1–40)
Total No. of surgeons 56
No. of surgeons per institution (median and range) 1 (1–10)
Total cases 5 (1–130)
Cases per year (median and range) 3 (1–36)
II. TGA
Enrollment period 1985–1989
Total no. of patients 829
No. of institutions 24
Total cases (median and range) 53 (1–169)
Arterial switch (median and range) 52 (1–146)
Atrial switch (median and range) 21 (1–31)
Cases per year (median and range) 12 (1–60)
Arterial switch per year (median and range) 17 (1–52)
Atrial switch per year (median and range) 5 (1–15)
No. of surgeons 50
No. of surgeons per institution (median and range) 1 (1–10)
Total cases per surgeon (median and range) 38 (1–87)
Cases per year per surgeon (median and range) 9 (1–28)
Arterial switch per year per surgeon 11 (1–28)
Atrial switch per year per surgeon 3 (1–12)
III. IAA
Enrollment period 1987–1997
Total no. of patients 474
No. of institutions 33
Total cases (median and range) 9 (1–57)
Cases per year (median and range) 3 (1–10)
IV PAIVS
Enrollment period 1987–1997
Total no. of patients 408
No. of institutions 33
Total cases (median and range) 17 (1–41)
Cases per year (median and range) 3 (1–9)
IAA, Interrupted aortic arch; TGA, transposition of the great arteries; PAIVS, pulmo-
nary atresia with intact ventricular septum.
TABLE 2. Impact of institution ‘‘experience’’ factors on risk-adjusted
mortality
Factor Parameter estimate P
± SE
Increased total case volume*
Norwood (per case) 0.002  0.001 .17
IAA (per case) 0.02  0.01 <.001
PAIVS (per case) 0.02  0.01 .07
TGA (per case) 0.02  0.01 <.001
Increased cases per yeary
Norwood (per case) 0.005  0.01 .38
IAA (per case) 0.03  0.03 .37
PAIVS (per case) 0.05  0.04 .24
TGA (per case) 0.07  0.02 <.001
Increased rank orderz
Norwood (per case) 0.002  0.002 .38
IAA (per case) 0.02  0.01 .06
PAIVS (per case) 0.02  0.01 .16
TGA (per case) 0.01  0.003 <.001
Increased case velocityx
Norwood (per case) 0.002  0.004 .15
IAA (per case) 0.01  0.01 .39
PAIVS (per case) 0.001  0.002 .76
TGA (per case) 0.002  0.002 .09
Increased total procedure timek
Norwood (per year) 0.04  0.03 0.17
IAA (per year) 0.04  0.05 0.36
PAIVS (per year) 0.07  0.04 0.05
TGA (per year) 0.24  0.08 0.002
IAA, Interrupted aortic arch; TGA, transposition of the great arteries; PAIVS, pulmo-
nary atresia with intact ventricular septum. *Total number of patients enrolled at
each institution during the entire study enrollment period. yTotal number of patients
enrolled by each institution divided by the number of years in which that institution
enrolled patients in each study. zFirst case through the last case in consecutive order.
xRank order of each case divided by the time interval in which a particular procedure
was performed. kDifference in years between the date of the last procedure and the date
of the first procedure during the study enrollment period.
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Dclear relationship between volume and performance was ev-
ident, but wide overlapping confidence intervals indicate
poor discrimination except between those institutions per-
forming at both extremes. Institutional excellence in manag-
ing some groups of neonates did not translate into equally
superior performance in their management of other groups
(Figure 4).Impact of Surgeon Factors and Learning Curve
Dynamics
Increasing surgeon ‘‘experience’’ was related to im-
proved survival for the TGA cohort (Table 3). Outcomes
for the arterial switch improved significantly with increasedThe Journal of Thoracic and Carank order of cases, indicating a potential learning curve
(Figure 5).
Conversely, there was no influence of surgeon ‘‘experi-
ence’’ on outcomes after the Norwood procedure (Table 3).
Risk-adjusted 5-year mortality was not significantly improved
despite increasing surgeon annual case volume (Figure 6).Neutralization of Risk: Management Paradigms as
Reasons for Improved Outcomes
Institution-specific models using the interaction terms re-
vealed one potential reason for improved institutional per-
formance in the Norwood series. Risk factors for mortality
identified from the overall model of all 710 neonates in-
cluded the patient-specific factor lower birth weight.15 How-
ever, one institution that enrolled 43 patients (total volume
range for all institutions: 3–155) achieved the best perfor-
mance because birth weight had little impact on survival
within this institution. The favorable results in this institu-
tion may derive not from volume, but from theirrdiovascular Surgery c Volume 139, Number 3 571
FIGURE 1. Risk-adjusted nomogram of 1-year mortality risk after the
Norwood procedure (on the vertical axis) versus annual volume of cases
(on the horizontal axis) with all other predictors from the overall model
excluding institutions (14) set to the median value. Mortality for all institu-
tions remains constant over the entire range of annual volume, indicating no
survival benefit with higher annual case volume. Note, however, that the
overall mortality during this era was approximately 40%. The continuous
parametric point estimates (solid lines) are enclosed by 70% confidence
intervals (dashed lines).
FIGURE 2. A, For the TGA cohort, there was a significant decrease in
mortality with increasing values for the ‘‘experience’’ domains we investi-
gated. Risk-adjusted nomogram of 1-year mortality risk versus annual vol-
ume of cases for the TGA cohort derived from the overall model excluding
institutions (25) shows a significant association between decreased mortal-
ity and increasing annual case volume. Less then 50 TGA cases per year is
associated with a rising mortality risk, indicating a potential threshold value.
Continuous parametric point estimates (solid line) enclosed by 70% confi-
dence intervals (dashed lines). B, Stratifying the nomogram by procedure
type, either arterial switch (n¼ 516) or atrial switch (n¼ 276) demonstrates
that the relationship between increased experience and better outcome is due
to improved results with the arterial switch.
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Dmanagement of a patient characteristic, ‘‘low birth weight,’’
which was a risk factor for all other institutions, but has been
neutralized in this institution (Figure 7).
Institutional protocols rather than volume or technical ex-
pertise per se are also implicated as the underlying reason for
improved outcomes in the PAIVS cohort. The institution
with the best results in PAIVS enrolled only 20 patients
but used a balanced management protocol based on mor-
phology. The morphologically driven protocol allowed
this institution to achieve comparably excellent survival,
with a high prevalence of biventricular repair and Fontan op-
eration, and few patients remaining unrepaired at age 5 years
(Figure 8).
DISCUSSION
Defining the impact of institution and surgeon experience
on outcomes in neonatal CHD is crucial in the current cli-
mate of extensive public scrutiny.30,31 The potential that par-
allel initiatives similar to those spearheaded by the Leapfrog
Group32 may be advocated in pediatric cardiac surgery fur-
ther highlight the importance of the establishment of a precise
and valid measure of performance. We report results from
the first study to use an academic database with a comprehen-
sive variable set to examine the influence of institution and
surgeon experience on outcomes for neonates beyond hospi-
tal discharge. We have shown that risk adjustment with data-
derived risk factors to ‘‘level the playing field’’ provides an
accurate method to compare and explain institutional perfor-
mance. Institution and surgeon experience are not the pri-
mary determinants of survival, but experience is more
important in some diagnostic groups than others.572 The Journal of Thoracic and Cardiovascular SurgPrevious Models for Risk Stratification
Recent methods of risk stratification in CHD surgery,
including the RACHS-1 and Aristotle Basic and Compre-
hensive scores, have been proposed as useful methods for
comparing inter-institutional outcomes.8,9 However,
although these scores may be statistically useful when
applied to a large group of patients with shared characteris-
tics, they lack precision in estimating risk for individual
patients.7,33 Furthermore, candidate risk factors used in these
systems have been consensus based rather than data
derived.11,33 Other problems with both the Aristotle and
RACHS systems, including procedure ‘‘groups’’ that are
not accommodated by the scoring systems, ambiguous or
redundant nomenclature, and insufficient variables to permitery c March 2010
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FIGURE 3. A, Institutional performance in the Norwood operation is shown as the mathematic difference between 5-year predicted survival after risk ad-
justment and actual 5-year survival (14). Institutions above the zero line are performing better than expected, whereas those below the zero line are performing
worse than expected. Institution code is listed on the bottom, and the number of patients enrolled is listed in the enclosed box. Institutions enrolling less than 10
patients are grouped together as less than 10. There is no relationship between increasing patient volume (surrogated by patient enrollment) and improved
outcomes. For example, institution 18, enrolling just 43 patients, performs better than institution 30 with 155 patients. B, Institutional performance for the
PAIVS cohort. Note that performance in this diagnostic group also is independent of total patient volume. Those institutions that performed the best in
the Norwood series (ie, institution 18) did not perform as well in this diagnostic group. C, Institutional performance for the TGA cohort measured at 15 years
from admission to hospital. The number of patients enrolled per institution is listed at the top horizontal, and the institution code is listed at the bottom hor-
izontal. Note that the highest volume institution is performing at the same level as an institution enrolling one eighth of the volume, but also notice that for this
diagnostic group, those institutions with higher volume generally have performance that exceeds expected levels. D, Institutional performance for the IAA
cohort. Note the overlapping confidence intervals. PAIVS, Pulmonary atresia with intact ventricular septum; TGA, transposition of the great arteries; IAA,
interrupted aortic arch.
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Dcomplete risk factor adjustment, have hampered widespread
acceptance of either system.3,11,14,33
Previous studies evaluating outcomes have used ‘‘early
death’’ in an attempt to simplify and standardize analysis.
However, ‘‘early’’ is arbitrary, being variously defined as
operative mortality (death within 30 days of operation and
before hospital discharge), in-hospital mortality (deathThe Journal of Thoracic and Caoccurring after operation and during the same hospital
admission as that operation), or 30-day mortality (death
occurring within 30 days of operation regardless of hospital
status).12-14 None of the former recognize that the risk of
death after operation changes over time. Typically the risk is
high at the time of operation but decreases rapidly to a lower
risk that is constant but not zero, and much later, the riskrdiovascular Surgery c Volume 139, Number 3 573
FIGURE 4. There were 6 CHSS institutions that contributed patients to all
4 diagnostic groups and had more than 10 patients within each group. These
institutions were ranked out of a total number of 31 institutions based on the
magnitude of difference between the predicted mortality at that institution
after risk adjustment and the actual mortality at that institution. Institutions
with the largest differential were ranked from lowest to highest, with a lower
number indicating superior performance. The institution number is listed
along the horizontal axis. Each geometric shape represents the individual in-
stitution’s performance within a particular diagnostic group. Institutional
excellence in managing certain diagnostic groups does not translate into ex-
cellence in managing all diagnostic groups. Note that institution 18 has ex-
cellent performance in the Norwood and IAA groups, but has the worst
performance in the PAIVS group. PAIVS, Pulmonary atresia with intact
ventricular septum; TGA, transposition of the great arteries; IAA, interrupted
aortic arch.
FIGURE 5. There was a significant positive association between increased
surgeon experience and improved outcomes for the TGA cohort that was
specific for the arterial switch operation. This nomogram shows a decline
in risk-adjusted 5-year mortality as a function of increasing case rank-order
per surgeon stratified by procedure type. Although mortality declines for
both procedures, there was a significant decrease in mortality only for the
arterial switch.
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Dincreases in a third phase. Risk factors that influence
outcome, either positively or negatively, in one phase may
or may not affect outcome in any of the other phases. The
early hazard phase of risk is unaffected by either the firstTABLE 3. Impact of surgeon ‘‘experience’’ factors on mortality
Factor Parameter estimate P
± SE
Norwood
Increased total case volume 0.001  0.001 .40
Increased cases per year 0.004  0.007 .49
Increased rank order 0.002  0.002 .91
Increased case velocity 0.006  0.001 .70
Increased procedure time 0.04  0.03 .26
TGA
Increased total case volume (per case) 0.01  0.004 .002
Increased cases per year (per case) 0.04  0.01 .002
Increased rank order (per case) 0.01  0.06 .009
Increased case velocity (per case) 0.004  0.002 .09
Increased procedure time (per year) 0.13  0.08 .10
Arterial switch
Increased rank order (per case) 0.04  0.01 .001
Atrial switch
Increased rank order (per case) 0.03  0.03 .41
SE, Standard error; TGA, transposition of the great arteries.
574 The Journal of Thoracic and Cardiovascular Surg30-day period after operation or by hospital discharge. The
CHSS report of outcomes in 710 neonates after the Norwood
operation, for example, documented an early phase mortality
that persisted beyond both hospital discharge and the 30-day
definition.15 Other CHSS studies, using techniques
described by Blackstone and others,15-24 used parametric
hazard function analysis to define both the phases of risk
and those factors that influence risk during a given phase
of follow-up.Impact of Institutional and Surgeon Factors on
Outcome
We have shown that survival of neonates with complex
CHD is influenced more by patient and management factors
than institution or surgeon experience. Despite similar com-
plexity, however, experience is clearly more important in
some lesions and procedures (the arterial switch for TGA)
than others (the Norwood procedure). In agreement with
our finding, Checchia and colleagues1 also found that out-
comes after the Norwood operation were independent of sur-
geon volume. What reasons underlie this disparate
influence? First, outcomes may be more dependent on expe-
rience for the arterial switch because operative technique is
the defining factor for the arterial switch operation, whereas
for the Norwood operation, the technical issues are over-
shadowed by the comparatively more complicated preoper-
ative and postoperative care. A patient who has had
a technically successful arterial switch operation, therefore,
does well with little requirement for critical postoperative
care. In contrast, an arterial switch operation that is techni-
cally compromised (eg, coronary stenosis) results in a high
risk of death irrespective of postoperative care. Second,ery c March 2010
FIGURE 6. Outcomes after the Norwood operation were not associated
with increased surgeon experience. Risk-adjusted nomogram shows that
5-year mortality after the Norwood operation is independent of the number
of cases done per year (annual case volume) per surgeon. Note the widening
confidence intervals once the annual volume reaches more than 30.
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FIGURE 8. Risk-adjusted competing-risks nomogram adapted from
Ashburn and colleagues22 for 1 institution on the basis of the morphologic
spectrum of PAIVS. This institution is one of two whose adoption of a mor-
phologically driven protocol allowed them to achieve comparably excellent
survival, with a higher prevalence of 2-ventricle and Fontan repair, with few
patients remaining unrepaired at 5 years.
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Dthe relatively narrow morphologic spectrum of TGA com-
pared with the wider morphologic spectrum of hypoplastic
left heart syndrome is also likely to increase the relative
importance of experience. Third, the TGA cohort circum-
scribed an earlier time period (1980s vs late 1990s for the
Norwood series) that included the introduction of a new
technique. It is probable that the strong influence of
increased experience in TGA outcomes is due to capturing
a learning curve for the arterial switch, which was missed
in the Norwood cohort.FIGURE 7. Risk-adjusted nomogram depicting 1-year mortality after the
Norwood operation as a function of increasing birth weight stratified by
whether a neonate was treated in institution 18 (the institution with the best
results) compared with all others. A 2.5-kg neonate undergoing the Nor-
wood operation in institution 18 fares significantly better than the same
neonate treated at any other institution. Favorable results in this particular
institution may derive from their management of a patient characteristic,
low birth weight, which was a risk factor for all other institutions, but has
been neutralized by institution 18. Continuous parametric point estimates
(solid lines) enclosed by 70% confidence limits (dashed lines).
The Journal of Thoracic and CaConcordant with these findings, Birkmeyer and col-
leagues2 found that the importance of hospital volume varied
markedly according to procedure type. They found that hos-
pital mortality for pancreatectomy and esophagectomy was
highly correlated with increasing caseload, whereas volume
had little impact on mortality after coronary artery bypass
grafting or carotid endarterectomy.
Our results are in contrast with those reported by others
who have examined the impact of volume on in-hospital or
30-day mortality,1-6,10,32,34-36 but they confirm the findings
of other recently published studies using large administrative
databases.36-38 Jenkins and colleagues4 reported signifi-
cantly decreased in-hospital mortality among those centers
performing greater than 300 cases annually in their analysis
of 2833 congenital heart operations performed at 37 centers.
Hannan and colleagues3 reached similar conclusions
whereby the odds ratio for hospital death was 1.42 in low-
volume institutions (annual volume<100 cases) when com-
pared with high-volume centers (annual volume 100
cases). They also found that increased annual surgeon case-
load (>75) significantly improved survival to hospital dis-
charge. Similarly, Allen and colleagues35 found that
evidenced-based referrals from a small volume (<50 cases
per year) to large volume (>300 cases per year) resulted in
a reduction in mortality after congenital heart surgery.
Different findings reported in our study are related to the
different end point used for comparison and our analytic
methods. We have used parametric time-related analysis
for mortality rather than logistic regression models fit for
an arbitrary end point: hospital or ‘‘early’’ death. Further,
the statistical models were risk adjusted on the basis of
data-derived variables derived from an academic database
rather than risk stratified on the basis of consensus-basedrdiovascular Surgery c Volume 139, Number 3 575
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best metric for ‘‘experience,’’ we used 5 different measures
for both institution and surgeon experience. Finally, the
relationship between volume and outcome may be different
given the considerable improvement in surgical outcomes in
the contemporary era.2 By using a measure of memory loss
termed ‘‘exponentially weighted moving average,’’ deLeval
and colleagues34 showed that mortality estimates can be
influenced when remote experiences are down-weighted
compared with more current experience.
Welke and colleagues37-39 used a large administrative da-
tabase, the Nationwide Inpatient Sample, to demonstrate the
inherent flaws in using case volume alone as a discriminator
of mortality. The relationship between hospital pediatric sur-
gical volume and in-hospital mortality was examined using
data from more than 55,000 pediatric cardiac surgical oper-
ations performed at more than 300 hospitals, using grouped
volume categories.37 These authors found that very small
hospitals (those performing 20 cases per year) had equiv-
alent mortality to that of large hospitals (those performing
>200 cases per year). Model discrimination using volume
was poor (c-statistic of 0.5), indicating that predictive ability
was no better than a coin flip. A subsequent analysis39 ex-
ploring volume–outcome relationships revealed, using sim-
ple power calculations, that an annual volume threshold of
525 operations would be required to detect a doubling of
the baseline mortality within the Nationwide Inpatient Sam-
ple database (from 4.2% to 8.4%) with a 20% type II error
rate.
We found considerable ranked performance variation
among institutions within each of 4 groups, with most institu-
tions falling within the 95% confidence intervals of predicted
survival. Difficulty achieving reasonable performance
discrimination between individual institutions because of
wide confidence intervals was also noted by Stark and col-
leagues6 in their review of all operations performed in the
United Kingdom between 1999 and 1998.
Our study also found that variation in performance among
different diagnostic groups occurred within an individual
institution. Excellent performance in one diagnostic group
did not indicate similar performance in all other groups. Im-
plications for evidence-based referral highlight the impor-
tance of defining the institutional distribution of specific
expertise.
Management Paradigms in Complex Congenital
Heart Disease
Institution-specific management paradigms rather than
increasing volume or other measures of ‘‘experience’’ may
provide solutions to such critically important problems as
the treatment of low birth weight neonates or refining the
selection criteria for specific repair pathways. We showed
that the institution with the best results in the Norwood
operation15 had neutralized an important risk factor that still576 The Journal of Thoracic and Cardiovascular Surgconfounds other institutions. Likewise, selection of neonates
for a single or biventricular repair pathway in one institution
based on a morphologic protocol led to superior results in
PAIVS.18 In support of this contention, Checchia and col-
leagues40 demonstrated a significant 1-year survival benefit
(50% vs 10%, P<.0001) for infants after the Norwood op-
eration by following the adoption of a preoperative selection
protocol that triaged infants to either Norwood or transplan-
tation on the basis of a weighed risk score.LIMITATIONS
Hierarchic models that account explicitly for within-
subject correlation among patients treated at one institution
and that introduce surgeon-level factors as random effects
(general estimating equations and mixed models) can be
easily applied for use in non-timed event analyses such as lo-
gistic regression. Hierarchic models may improve discrimi-
nation among institutions by reducing variance between
each institution.22 However, software that integrates fixed
and random effects within multiphase parametric models is
not presently available.
CHSS member institutions represent a select group of hos-
pitals, and submission of data was voluntary for these studies.
It is possible, therefore, that the lack of a clear volume–
outcome relationship in this study may be due to selection
bias, and the results may not be applicable to non-CHSS
institutions.
We were unable to quantitate accurately the total opera-
tive experience of each individual surgeon because of
several factors. These 4 CHSS studies spanned several
decades in which migration of surgeons to different institu-
tions over time presumably occurred. Further, formal certifi-
cation in congenital heart surgery has not existed until 2007,
making it impossible to determine with certainty a definitive
end point for training.CONCLUSIONS
Institution and surgeon experience is not the only factor
influencing outcomes in complex CHD. Experience cannot
be singularly defined as volume and should be evaluated
as a composite measure. Considerable overlap in ranked
performance exists among institutions, and discrimination
is likely to further decline with the overall improvement in
outcomes and the ‘‘shrinking’’ margin of error. Excellent
institutional performance in managing one diagnostic group
does not indicate similar performance for all other diagno-
ses. Valid comparisons of institution and surgeon outcomes
could provide a mechanism to improve results in institutions
with less favorable outcomes.References
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TABLE E1. Multivariable models for overall mortality
Norwood*
Birth weight (kg)
Age at operation (d)
Circulatory arrest time (min)
Ascending aortic dimension (mm)
Reimplantation of the ascending aorta (yes/no)
Shunt origin from the aorta (yes/no)
Interaction term between ascending aortic diameter
and ascending aortic diameter
Interrupted aortic archy
Date of birth (squared transformation)
Weight at repair (inverse transformation)
Truncus arteriosus (yes/no)
IAA type B or C (yes/no)
VSD not large (yes/no)
Absence of malalignment of the VSD (yes/no)
No augmentation of the aortic arch at IAA repair (yes/no)
Main pulmonary artery-aorta anastomosis performed at IAA repair
(yes/no)
Pulmonary atresia with intact ventricular septumz
Graded spectrum of right ventricular size (square transformation)
Tricuspid valve Z-score
Higher left ventricular pulse pressure (mm Hg)
Birth weight (kg)
Transposition of the great arteriesx
Birth weight (kg)
Age at repair (d)
Female gender (yes/no)
Major associated cardiac anomalies (yes/no)
Major associated noncardiac anomalies (yes/no)
Number of pre-repair procedures
Simple TGA (yes/no)
Moderate or large VSD (yes/no)
Multiple VSDs (yes/no)
Degree of pulmonary stenosis
Repair type
Arterial switch
Atrial switch
Rastelli
Use of circulatory arrest (yes/no)
Circulatory arrest time (min)
CrossClamp time (min)
IAA, Interrupted aortic arch; VSD, ventricular septal defect; TGA, transposition of the
great arteries. *Norwood model from Ashburn DA, McCrindle BW, Tchervenkov CI,
Jacobs ML, Lofland GK, Bove EL, et al. Outcomes after the Norwood operation in
neonates with critical aortic stenosis or aortic valve atresia. J Thorac Cardiovasc
Surg. 2003;125:1070-82. yIAA model from McCrindle BW, Tchervenkov CI, Kon-
stantinov IE, Neirotti RA, Jacobs ML, Blackstone EH. Risk factors associated with
mortality and reinterventions in 474 neonates with interruption of the aortic arch:
a Congenital Heart Surgeons Society Study. J Thorac Cardiovasc Surg.
2005;129:343-50. zPAIVS model adapted from Ashburn DA, Blackstone EH, Wells
WJ, Jonas RA, Pigula FA, Lofland GK, et al. Determinants of mortality and type of
repair in neonates with pulmonary atresia-intact ventricular septum. J Thorac Cardi-
ovasc Surg. 2004;127:1000-8. xTGA model from Williams WG, MsCrindle BW, Ash-
burn DA, Jonas RA, Mavroudis C, Blackstone EH. Outcomes of 829 neonates with
complete transposition of the great arteries 12-17 years after repair. Eur J Cardio-
thorac Surg. 2003;24:1-10.
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